South & Central America Intradermal Injections Market is expected to reach US$ 424.6 million by 2028


PRESS RELEASE BY The Insight Partners 15 Mar 2022

Share this press on


Normal-sized Needles Segment has the Largest Share of Method in the South & Central America Intradermal Injections Market during 2021–2028

According to our latest study on “South & Central America Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Analysis – by Method, Application, and End User,” the market is projected to reach US$ 424.6 million by 2028 from US$ 213.9 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of tuberculosis and allergic reactions along with rising acceptance of intradermal injection in cosmetic surgeries. However, injection site reactions and dossing limitations associated with intradermal injections shall restrict the market growth during the forecast period, to a noticeable extent.

The outbreak of COVID–19 has stringently affected medical services in the South and Central America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. It is anticipated that the region will again implement some restrictions, which will eventually hamper the healthcare industry in the area. Market players and end-user losses their business due to the based treatment and diagnosis are stopped. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is currently facing third wave of corona infection. Amongst which Brazil has registered most of the deaths. It is anticipated that the region will likely implement some restrictions, which will ultimately hamper the healthcare industry in the area. However, the outbreak of COVID–19 has critically affected the flow of medical services in the region. Further, the cases of allergies also increase during the COVID19 period, which results in the rise in the number of diagnostic tests. In addition, the nations are famous for medical tourism, which is also affected by the pandemic. Brazil, Chile, Peru, Argentina, Uruguay, Colombia is affected by the corona infection.

Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share, short needles segment is expected to grow at the highest CAGR in the forecast period.

BD, West Pharmaceutical Services, Inc., Terumo Corporation, NanoPass, Pharmajet, Idevax, EUNSUNG GLOBAL, Crossject, Cardinal Health Inc., and Hindustan Syringes and Medical Devices Ltd are among the leading companies in the South & Central America intradermal injections market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for intradermal injections market is segmented into method, application, and end user. Based on method, the South & Central America intradermal injections market is segmented into normal-sized needles, short needles, and without needles. Based on application, the intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others.  Based on end user, the intradermal injections market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. Geographically, the intradermal injections market is segmented into South & Central America (Brazil, Argentina, Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
 

Download Free PDF Brochure